A new cancer treatment more potent than the best-selling cancer drug taxol is
working well in human trials. Epothilone, which comes from soil-dwelling
organisms called myxobacteria, stops cancer cells dividing as taxol does. When a
cell splits in two, elastic protein threads draw the chromosomes apart. But
epothilone binds to these “tubulins” and halts a tumour’s runaway cell division.
“Epothilone stops the chromosomes from being pulled apart,” says Herbie Newell
of the Newcastle University Cancer Research Unit.
To continue reading, today with our introductory offers
Advertisement
More from New ¾«¶«´«Ã½
Explore the latest news, articles and features
Life
New ¾«¶«´«Ã½ recommends a brilliant take on the evolution of birds
Culture
Environment
Striking photos show how sands are encroaching on oases in the Sahara
Regulars
Comment
Think you have a good sense of humour? So do most people…
Regulars
Comment
Sci-fi horror film Backrooms is a triumph for its 20-year-old director
Culture
Popular articles
Trending New ¾«¶«´«Ã½ articles
1
Fully autonomous drones have killed human soldiers for the first time
2
Mysterious ‘cold blob’ in the Atlantic suggests the AMOC is weakening
3
Pancreatic cancer halted by virus injection in three patients
4
Understanding anorexia’s grip on the brain could unlock new therapies
5
Millions of fossil whale bones found in deep-ocean ‘necropolis’
6
Unpicking endometriosis reveals how it affects more than the pelvis
7
Why we should all take quantum physics extremely personally
8
Dinosaur-killing asteroid impact site stayed hot for millions of years
9
Robots are about to overtake armed soldiers as the deciders of war
10
What to read this week: Katrina Manson's terrifying Project Maven
